Strategic Report Key Information Investment objective and policy Worldwide Healthcare Trust PLC is a specialist investment trust that invests in the global healthcare sector with the objective of achieving a high level of capital growth.
In order to achieve its investment objective, the Company invests worldwide in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector.
It uses gearing, and derivative transactions to enhance returns and mitigate risk.
Performance is measured against the MSCI World Health Care Index on a net total return, sterling adjusted basis Benchmark.
Further details of the Companys investment policy are set out in the Strategic Report on pages 6 and 7.
Accessing the global market The healthcare sector is global and accessing this market as a UK investor can be difficult.
Within the UK, there are diminishing options for investment as the universe of healthcare companies is shrinking through merger and acquisition activity.
The Company offers an opportunity to gain exposure to pharmaceutical, biotechnology and related companies in the healthcare sector on a global scale.
Among healthcare funds, Worldwide Healthcare Trust PLC is unique due to its broad investment mandate allowing it to participate in all aspects of healthcare, anywhere in the world.
These can range from patented specialty medicines for small patient populations to unpatented generic drugs, in both developed countries and emerging markets.
In addition, the Company invests in medical device technologies, life science tools and healthcare services.
The overall geographic spread of Worldwide Healthcare Trust PLC is unique among healthcare funds, with investments in the U. S. Europe, Japan and emerging markets.
How to invest The Companys shares are traded openly on the London Stock Exchange and can be purchased through a stock broker or other financial intermediary.
The shares are available through savings plans including investment dealing accounts, ISAs, Junior ISAs and SIPPs which enable both regular monthly investments and lump sum investments in the Companys shares.
There are a number of investment platforms that offer these facilities.
Further details can be found on pages 74 and 75.
Total return performance since launch to 31 March 2017 % 3500 3000 2500 2000 1500 1000 500 0 WWH NAV per Share total return WWH Share Price total return Benchmark total return Rebased to 100 as at 28 April 1995 Source: Morningstar, Thomson Reuters & Bloomberg With effect from 1 October 2010, the performance of the Company is measured against the MSCI World Health Care Index on a net total return, sterling adjusted basis.
Prior to this date, performance was measured against the Datastream World Pharmaceutical & Biotechnology Index total return, sterling adjusted.
Worldwide Healthcare Trust PLC 02 Annual Report for the year ended 31 March 2017 Apr 95 Mar 96 Mar 97 Mar 98 Mar 99 Mar 00 Mar 01 Mar 02 Mar 03 Mar 04 Mar 05 Mar 06 Mar 07 Mar 08 Mar 09 Mar 10 Mar 11 Mar 12 Mar 13 Mar 14 Mar 15 Mar 16 Mar 17 Strategic Report Company Performance Historic performance for the years ended 31 March 2012 2013 2014 2015 2016 2017 Net asset value per share total return 14.4% 30.3% 25.9% 53.0% 9.0% 28.9% Benchmark total return 13.4% 31.4% 14.9% 35.9% 5.4% 24.5% Net asset value per share basic 909.4p 1110.2p 1374.3p 2039.3p 1850.9p 2,367.2p Net asset value per share diluted 871.0p 1089.6p 1348.2p 2039.3p 1850.5p 2,367.2p Share price 795.0p 1009.0p 1301.0p 1930.0p 1715.0p 2,304.0p Discount of share price to diluted net asset value per share 8.7% 7.4% 3.5% 5.4% 7.3% 2.7% Dividends per share 17.5p 16.5p 15.0p 12.5p 16.5p 22.5p Leverage 25.1% 12.7% 13.9% 13.2% 14.0% 16.9% Ongoing charges 1.1% 1.0% 1.0% 1.0% 0.9% 0.9% Ongoing charges including performance fees paid or crystallised during the year 1.3% 1.2% 1.1% 2.2% 2.1% 1.0% Source: Morningstar Dilution to take account of the Companys Subscription Shares which expired on 31 July 2014 and any shares held in treasury.
See Glossary beginning on page 72.
Five year total return performance to 31 March 2017 % 340 300 260 220 180 140 100 60 Benchmark total return WWH Share Price total return WWH NAV per Share total return Rebased to 100 as at 31 March 2012 Source: Morningstar Worldwide Healthcare Trust PLC Annual Report for the year ended 31 March 2017 03 Mar 12 Mar 13 Mar 14 Mar 15 Mar 16 Mar 17
